Heterologous production of plant-derived isoprenoid products in microbes and the application of metabolic engineering and synthetic biology

Current Opinion in Plant Biology

Volumn 19, Issue , 2014, Pages 8-13

  Li, Yi ^a   Pfeifer, Blaine A ^a  

^a the State University of New York   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TERPENE;

METABOLIC ENGINEERING; METABOLISM; PLANT; SYNTHETIC BIOLOGY;

METABOLIC ENGINEERING; PLANTS; SYNTHETIC BIOLOGY; TERPENES;

EID: 84897073422     PISSN: 13695266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbi.2014.02.005     Document Type: Review

References (50)

1. Ajikumar P.K., Xiao W.H., Tyo K.E.J., Wang Y., Simeon F., Leonard E., Mucha O., Phon T.H., Pfeifer B., Stephanopoulos G. Isoprenoid pathway optimization for taxol precursor overproduction in Escherichia coli. Science 2010, 330:70-74.
2. Paddon C.J., Westfall P.J., Pitera D.J., Benjamin K., Fisher K., McPhee D., Leavell M.D., Tai A., Main A., Eng D., et al. High-level semi-synthetic production of the potent antimalarial artemisinin. Nature 2013, 496:528-532.
3. Raskin I., Ribnicky D.M., Komarnytsky S., Ilic N., Poulev A., Borisjuk N., Brinker A., Moreno D.A., Ripoll C., Yakoby N., et al. Plants and human health in the twenty-first century. Trends Biotechnol 2002, 20:522-531.
4. Itokawa H., Morris-Natschke S.L., Akiyama T., Lee K.H. Plant-derived natural product research aimed at new drug discovery. J Nat Med 2008, 62:263-280.
5. Patil R.A., Kolewe M.E., Roberts S.C. Cellular aggregation is a key parameter associated with long term variability in paclitaxel accumulation in Taxus suspension cultures. Plant Cell Tissue Organ Cult 2013, 112:303-310.
6. Smetanska I. Production of secondary metabolites using plant cell cultures. Adv Biochem Eng Biotechnol 2008, 111:187-228.
7. Mitchell W. Natural products from synthetic biology. Curr Opin Chem Biol 2011, 15:505-515.
8. Keasling J.D. Synthetic biology and the development of tools for metabolic engineering. Metab Eng 2012, 14:189-195.
9. Wilson S.A., Roberts S.C. Recent advances towards development and commercialization of plant cell culture processes for the synthesis of biomolecules. Plant Biotechnol J 2012, 10:249-268.
10. Danishefsky S.J., Masters J.J., Young W.B., Link J.T., Snyder L.B., Magee T.V., Jung D.K., Isaacs R.C.A., Bornmann W.G., Alaimo C.A., et al. Total synthesis of baccatin III and taxol. J Am Chem Soc 1996, 118:2843-2859.
11. Baloglu E., Kingston D.G. A new semisynthesis of paclitaxel from baccatin III. J Nat Prod 1999, 62:1068-1071.
12. Ongley S.E., Bian X., Neilan B.A., Muller R. Recent advances in the heterologous expression of microbial natural product biosynthetic pathways. Nat Prod Rep 2013, 30:1121-1138.
13. Zhang H., Boghigian B.A., Armando J., Pfeifer B.A. Methods and options for the heterologous production of complex natural products. Nat Prod Rep 2011, 28:125-151.
14. Misawa N., Nakagawa M., Kobayashi K., Yamano S., Izawa Y., Nakamura K., Harashima K. Elucidation of the Erwinia uredovora carotenoid biosynthetic pathway by functional analysis of gene products expressed in Escherichia coli. J Bacteriol 1990, 172:6704-6712.
15. Yamano S., Ishii T., Nakagawa M., Ikenaga H., Misawa N. Metabolic engineering for production of beta-carotene and lycopene in Saccharomyces cerevisiae. Biosci Biotechnol Biochem 1994, 58:1112-1114.
16. Shimada H., Kondo K., Fraser P.D., Miura Y., Saito T., Misawa N. Increased carotenoid production by the food yeast Candida utilis through metabolic engineering of the isoprenoid pathway. Appl Environ Microbiol 1998, 64:2676-2680.
17. Harker M., Bramley P.M. Expression of prokaryotic 1-deoxy-d-xylulose-5-phosphatases in Escherichia coli increases carotenoid and ubiquinone biosynthesis. FEBS Lett 1999, 448:115-119.
18. Wang C., Oh M.K., Liao J.C. Directed evolution of metabolically engineered Escherichia coli for carotenoid production. Biotechnol Prog 2000, 16:922-926.
19. Farmer W.R., Liao J.C. Precursor balancing for metabolic engineering of lycopene production in Escherichia coli. Biotechnol Prog 2001, 17:57-61.
20. Alper H., Miyaoku K., Stephanopoulos G. Construction of lycopene-overproducing E. coli strains by combining systematic and combinatorial gene knockout targets. Nat Biotech 2005, 23:612-616.
21. Jin Y.S., Stephanopoulos G. Multi-dimensional gene target search for improving lycopene biosynthesis in Escherichia coli. Metab Eng 2007, 9:337-347.
22. Wang H.H., Isaacs F.J., Carr P.A., Sun Z.Z., Xu G., Forest C.R., Church G.M. Programming cells by multiplex genome engineering and accelerated evolution. Nature 2009, 460:894-898.
23. Tyo K.E., Ajikumar P.K., Stephanopoulos G. Stabilized gene duplication enables long-term selection-free heterologous pathway expression. Nat Biotechnol 2009, 27:760-765.
24. Choi H.S., Lee S.Y., Kim T.Y., Woo H.M. In silico identification of gene amplification targets for improvement of lycopene production. Appl Environ Microbiol 2010, 76:3097-3105.
25. Chen Y.Y., Shen H.J., Cui Y.Y., Chen S.G., Weng Z.M., Zhao M., Liu J.Z. Chromosomal evolution of Escherichia coli for the efficient production of lycopene. BMC Biotechnol 2013, 13:1472-6750.
26. Zhang C., Chen X., Zou R., Zhou K., Stephanopoulos G., Too H.P. Combining genotype improvement and statistical media optimization for isoprenoid production in E. coli. PLoS ONE 2013, 8:0075164.
27. Martin V.J.J., Pitera D.J., Withers S.T., Newman J.D., Keasling J.D. Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nat Biotech 2003, 21:796-802.
28. Lindahl A.-L., Olsson M., Mercke P., Tollbom Ö., Schelin J., Brodelius M., Brodelius P. Production of the artemisinin precursor amorpha-4,11-diene by engineered Saccharomyces cerevisiae. Biotechnol Lett 2006, 28:571-580.
29. Ro D.K., Paradise E.M., Ouellet M., Fisher K.J., Newman K.L., Ndungu J.M., Ho K.A., Eachus R.A., Ham T.S., Kirby J., et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 2006, 440:940-943.
30. Newman J.D., Marshall J., Chang M., Nowroozi F., Paradise E., Pitera D., Newman K.L., Keasling J.D. High-level production of amorpha-4,11-diene in a two-phase partitioning bioreactor of metabolically engineered Escherichia coli. Biotechnol Bioeng 2006, 95:684-691.
31. Pitera D.J., Paddon C.J., Newman J.D., Keasling J.D. Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coli. Metab Eng 2007, 9:193-207.
32. Komatsu M., Uchiyama T., Omura S., Cane D.E., Ikeda H. Genome-minimized Streptomyces host for the heterologous expression of secondary metabolism. Proc Natl Acad Sci U S A 2010, 107:2646-2651.
33. Farhi M., Marhevka E., Masci T., Marcos E., Eyal Y., Ovadis M., Abeliovich H., Vainstein A. Harnessing yeast subcellular compartments for the production of plant terpenoids. Metab Eng 2011, 13:474-481.
34. Zhou K., Zou R., Zhang C., Stephanopoulos G., Too H.-P. Optimization of amorphadiene synthesis in Bacillus subtilis via transcriptional, translational, and media modulation. Biotechnol Bioeng 2013, 110:2556-2561.
35. Huang Q., Roessner C.A., Croteau R., Scott A.I. Engineering Escherichia coli for the synthesis of taxadiene, a key intermediate in the biosynthesis of taxol. Bioorg Med Chem 2001, 9:2237-2242.
36. DeJong J.M., Liu Y.L., Bollon A.P., Long R.M., Jennewein S., Williams D., Croteau R.B. Genetic engineering of Taxol biosynthetic genes in Saccharomyces cerevisiae. Biotechnol Bioeng 2006, 93:212-224.
37. Engels B., Dahm P., Jennewein S. Metabolic engineering of taxadiene biosynthesis in yeast as a first step towards Taxol (Paclitaxel) production. Metab Eng 2008, 10:201-206.
38. Carr P.A., Church G.M. Genome engineering. Nat Biotechnol 2009, 27:1151-1162.
39. Fuller C.W., Middendorf L.R., Benner S.A., Church G.M., Harris T., Huang X., Jovanovich S.B., Nelson J.R., Schloss J.A., Schwartz D.C., et al. The challenges of sequencing by synthesis. Nat Biotechnol 2009, 27:1013-1023.
40. Patti G.J., Yanes O., Siuzdak G. Innovation: metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol 2012, 13:263-269.
41. Kaltashov I.A., Bobst C.E., Abzalimov R.R., Wang G., Baykal B., Wang S. Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics. Biotechnol Adv 2012, 30:210-222.
42. Blazeck J., Alper H.S. Promoter engineering: recent advances in controlling transcription at the most fundamental level. Biotechnol J 2013, 8:46-58.
43. Wang H.H., Kim H., Cong L., Jeong J., Bang D., Church G.M. Genome-scale promoter engineering by coselection MAGE. Nat Methods 2012, 9:591-593.
44. Enyeart P.J., Ellington A.D. Synthetic biology: a yeast for all reasons. Nature 2011, 477:413-414.
45. Pfeifer B.A., Admiraal S.J., Gramajo H., Cane D.E., Khosla C. Biosynthesis of complex polyketides in a metabolically engineered strain of E. coli. Science 2001, 291:1790-1792.
46. Woolston B.M., Edgar S., Stephanopoulos G. Metabolic engineering: past and future. Annu Rev Chem Biomol Eng 2013, 4:259-288.
47. Prather K.L.J., Martin C.H. De novo biosynthetic pathways: rational design of microbial chemical factories. Curr Opin Biotechnol 2008, 19:468-474.
48. Dietrich J.A., Yoshikuni Y., Fisher K.J., Woolard F.X., Ockey D., McPhee D.J., Renninger N.S., Chang M.C., Baker D., Keasling J.D. A novel semi-biosynthetic route for artemisinin production using engineered substrate-promiscuous P450(BM3). ACS Chem Biol 2009, 4:261-267.
49. Dai Z., Liu Y., Zhang X., Shi M., Wang B., Wang D., Huang L., Zhang X. Metabolic engineering of Saccharomyces cerevisiae for production of ginsenosides. Metab Eng 2013, 11:146-156.
50. Gibson D.G., Glass J.I., Lartigue C., Noskov V.N., Chuang R.Y., Algire M.A., Benders G.A., Montague M.G., Ma L., Moodie M.M., et al. Creation of a bacterial cell controlled by a chemically synthesized genome. Science 2010, 329:52-56.